← Leaderboards
John Christian Tilton
University Of Pennsylvania
$9,489,854
Attributed
$9,489,854
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,489,854 · 8
By mechanism
R01$5,328,696 · 3
UG3$2,079,441 · 1
P30$967,555 · 1
R56$515,282 · 1
R21$435,875 · 1
F32$163,005 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- E. Jane Albert Hubbard$13,066,235
- Irving M Shapiro$13,291,729
- Maurizio Pacifici$19,366,698
- Sara Cherry$26,280,643
- Kurt T Barnhart$21,863,411
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralCellsVirusBaseNovel StrategiesProteomicsCell LineInfectionAffectResistanceSamplingBiologicalMonitorIn VitroPharmaceutical PreparationsTechnologyPredispositionCd4 Positive T LymphocytesHiv-1AntibodiesMutationProteinsDetectionIn Vivo
Grant awards (24)
The role of the precursor HIV-1 protease in drug resistance.$507,792
R01 · FY2025 · AI · contact PI
Core E: Viral Pathogenesis & Persistence$198,499
P30 · FY2025 · AI · contact PI
Gaining a clear view of HIV cell-cell spread using APEX proximity labeling$515,282
R56 · FY2024 · AI · contact PI
Core E: Viral Pathogenesis & Persistence$248,889
P30 · FY2024 · AI · contact PI
Novel approaches to understanding precursor protease autoprocessing in intact viruses$517,016
R01 · FY2023 · AI · contact PI
Core E: Viral Pathogenesis & Persistence$256,460
P30 · FY2023 · AI · contact PI
Novel approaches to understanding precursor protease autoprocessing in intact viruses$517,016
R01 · FY2022 · AI · contact PI
Core E: Viral Pathogenesis & Persistence$263,707
P30 · FY2022 · AI · contact PI
In vivo delivery of CRISPR Cas9-guide RNA nucleoprotein complexes using the nanoPOD platform$694,345
UG3 · FY2021 · HL · contact PI
Novel approaches to understanding precursor protease autoprocessing in intact viruses$517,016
R01 · FY2021 · AI · contact PI
In vivo delivery of CRISPR Cas9-guide RNA nucleoprotein complexes using the nanoPOD platform$694,345
UG3 · FY2020 · HL · contact PI
Novel approaches to understanding precursor protease autoprocessing in intact viruses$516,213
R01 · FY2020 · AI · contact PI
In vivo delivery of CRISPR Cas9-guide RNA nucleoprotein complexes using the nanoPOD platform$690,751
UG3 · FY2019 · HL · contact PI
Novel approaches to understanding precursor protease autoprocessing in intact viruses$513,805
R01 · FY2019 · AI · contact PI
Enhancement of HIV transmission by hormones and bacterial metabolites$320,057
R01 · FY2017 · HD · contact PI
Enhancement of HIV transmission by hormones and bacterial metabolites$482,748
R01 · FY2016 · HD · contact PI
Enhancement of HIV transmission by hormones and bacterial metabolites$475,434
R01 · FY2015 · HD · contact PI
Detection of Latent HIV Infection Using Selective Reaction Monitoring Mass Spectr$158,500
R21 · FY2015 · AI · contact PI
Enhancement of HIV transmission by hormones and bacterial metabolites$473,974
R01 · FY2014 · HD · contact PI
Detection of Latent HIV Infection Using Selective Reaction Monitoring Mass Spectr$277,375
R21 · FY2014 · AI · contact PI
Enhancement of HIV transmission by hormones and bacterial metabolites$487,625
R01 · FY2013 · HD · contact PI
Mechanisms of HIV Resistance to CCR5 Inhibitors and Consequences for Pathogenesis$46,901
F32 · FY2010 · AI · contact PI
Mechanisms of HIV Resistance to CCR5 Inhibitors and Consequences for Pathogenesis$59,402
F32 · FY2009 · AI · contact PI
Mechanisms of HIV Resistance to CCR5 Inhibitors and Consequences for Pathogenesis$56,702
F32 · FY2008 · AI · contact PI